Skip to main content

Table 4 Missed Day 1 dosing of artesunate injection among 57 hospitalized patients who received in-hospital intravenous artesunate, Uganda, 2014

From: Quality of care for adult in-patients with malaria in a tertiary hospital in Uganda

Length of stay, days Preadmission anti-malarial use Admission Malaria Diagnosis Discharge Malaria Diagnosis AL co-prescribed Switched to AL AS Doses Prescribed AS Doses Received Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8
3 No Yes No No No 3 1   1 dose       
3 No Yes Yes Yes No 2 3 1 dose 2 doses       
4 No Yes Yes No No 6 2 1 dose 1 dose       
5 No Yes Yes Yes No 3 3 1 dose 1 dose 1 dose      
2 No Yes Yes Yes No 2 1 1 dose        
4 Yes Yes Yes Yes No 10 3 1 dose   1 dose 1 dose     
5 No No No No No 3 2   2 doses       
2 No Yes Yes Yes Yes 3 2 2 doses        
4 No Yes No Yes Yes 3 2 1 dose 1 dose       
5 Yes Yes Yes Yes Yes 3 1 1 dose        
4 No Yes Yes Yes No 3 2 1 dose 1 dose       
5 No Yes Yes No No 3 4   1 dose 2 doses 1 dose     
5 No Yes Yes No No 3 3 1 dose 1 dose 1 dose      
5 No Yes No No No 3 3   1 dose 1 dose 1 dose     
10 Yes Yes No No No 3 2 1 dose 1 dose       
3 Yes No No No No 2 3 1 dose 2 doses       
5 Yes Yes Yes Yes No 2 2 1 dose 1 dose       
2 No Yes Yes Yes No 3 2 1 dose 1 dose       
3 No Yes Yes Yes No 2 3 2 doses 1 dose       
10 No No No No No 3 4   1 dose 1 dose 2 doses     
3 No Yes Yes Yes No 3 2   2 doses       
5 No No Yes Yes No 2 3   1 dose 1 dose 1 dose     
2 No Yes Yes Yes No 4 1 1 dose        
3 Yes Yes Yes Yes No 4 3 1 dose 1 dose 1 dose      
3 No Yes Yes Yes No 3 3 1 dose 2 doses       
3 Yes Yes Yes No No 3 3 1 dose 1 dose 1 dose      
3 Yes Yes Yes Yes No 3 2 1 dose 1 dose       
5 Yes Yes Yes Yes No 3 4 1 dose 1 dose 1 dose 1 dose     
4 Yes Yes Yes Yes No 3 3 1 dose 1 dose 1 dose      
3 Yes Yes Yes Yes No 3 3 1 dose 1 dose 1 dose      
5 Yes Yes Yes Yes No 3 3 1 dose   1 dose 1 dose     
7 Yes Yes Yes Yes Yes 3 3 1 dose     1 dose 1 dose   
5 No No No Yes No 3 3   1 dose 1 dose 1 dose     
3 Yes Yes Yes Yes No 3 2 1 dose 1 dose       
4 No Yes Yes No No 3 2 1 dose 1 dose       
2 No Yes Yes Yes No 3 1 1 dose        
9 No Yes Yes No No 3 2 1 dose 1 dose       
6 No Yes Yes No No 3 3     1 dose 2 doses    
3 Yes No No Yes No 3 1 1 dose        
4 No Yes Yes Yes No 3 3   1 dose 2 doses      
3 Yes Yes No Yes No 3 3 1 dose 2 doses       
4 No Yes Yes No No 3 3 1 dose 1 dose 1 dose      
3 Yes No Yes Yes No 3 3 1 dose 2 doses       
4 Yes Yes Yes Yes No 3 3   1 dose 2 doses      
9 No Yes Yes Yes Yes 4 3    1 dose 1 dose 1 dose    
4 Yes Yes No Yes Yes 2 3   2 doses 1 dose      
4 No Yes Yes Yes No 6 2    1 dose 1 dose     
3 No Yes Yes Yes Yes 1 1 1 dose        
16 Yes Yes No No No 3 3 1 dose 2 doses       
4 No Yes Yes No No 3 1 1 dose        
6 No Yes No No No 3 4 1 dose 1 dose 2 doses      
5 No Yes Yes Yes No 3 3   2 doses 1 dose      
3 No Yes No No No 1 1 1 dose        
3 No Yes Yes Yes No 3 1   1 dose       
4 Yes No No No No 2 2 1 dose 1 dose       
15 Yes No Yes No No 3 8 1 dose 2 doses   1 dose 2 doses    2 doses
1 No Yes Yes Yes No 2 2 1 dose 1 dose       
Missed-dose day, n 16 10 8 1 1    
Dose-day data unavailable, n1 0 5 27 44 52    
Dose-day data available, N* 57 52 30 13 5    
Proportion of in-patients with missed Day 1 data, n/N ~  28%        
  1. The variation from 1 to 2 AS doses per calendar day depends on the time of day that an in-patient initiates treatment. Injectable AS is given at 0, 12, 24 h then in-patient is switched to oral AL if he/she can tolerate it. Thus, an in-patient might receive 1 to 2 AS doses per calendar-day and very rarely 3 AS doses
  2. *N = [(The 57 artesunate users) – (Number of in-patients who did not have artesunate dose-day data)] or (57-n1); ~ 95% confidence intervals for the estimate is 28% (17–42%)